The Burden Of Illness and Prevalence In Diffuse Large B-Cell (DLBCL) and Follicular (FL) Lymphomas

被引：4
|
作者：
Dulac, Edward J., III
Joy, Karen A.
Ndindjock, Roger
Coyle, Katharine B.
Wade, Rolin L.
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.5619.5619
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5619
引用
收藏
页数：2
相关论文
共 50 条
  • [1] PATIENTS WITH FOLLICULAR LYMPHOMA (FL) SHOWING A DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) COMPONENT HAVE AN INTERMEDIATE OUTCOME BETWEEN FL AND DLBCL
    Magnano, L.
    Balague, O.
    Dlouhy, I.
    Rovira, J.
    Karube, K.
    Rivas, A.
    Gonzalez, B.
    Martinez-Trillos, A.
    Martinez, A.
    Delgado, J.
    Gine, E.
    Villamor, N.
    Campo, E.
    Lopez-Guillermo, A.
    HAEMATOLOGICA, 2016, 101 : 273 - 274
  • [2] PRAMS Expression in Follicular Lymphoma (FL) and Diffuse Large B Cell Lymphoma (DLBCL)
    Perez, M.
    Shafer, J. A.
    Curry, C.
    Zu, Y.
    Ewton, A.
    Dotti, G.
    Chang, C.
    MODERN PATHOLOGY, 2009, 22 : 280A - 281A
  • [3] PRAME Expression in Follicular Lymphoma (FL) and Diffuse Large B Cell Lymphoma (DLBCL)
    Perez, M.
    Shafer, J. A.
    Curry, C.
    Zu, Y.
    Ewton, A.
    Dotti, G.
    Chang, C.
    LABORATORY INVESTIGATION, 2009, 89 : 280A - 281A
  • [4] MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas
    Roehle, Anja
    Hoefig, Kai P.
    Repsilber, Dirk
    Thorns, Christoph
    Ziepert, Marita
    Wesche, Kai O.
    Thiere, Marlen
    Loeffler, Markus
    Klapper, Wolfram
    Pfreundschuh, Michael
    Matolcsy, Andras
    Bernd, Heinz-Wolfram
    Reiniger, Lila
    Merz, Hartmut
    Feller, Alfred C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 142 (05) : 732 - 744
  • [5] MicroRNA expression profiling characterize diffuse large B-Cell lymphomas and follicular lymphomas
    Roehle, Anja
    Hoefig, Kai P.
    Repsilber, Dirk
    Thorns, Christoph
    Wesche, Kai O.
    Kaehler, Christian
    Klapper, Wolfram
    Pfreundschuh, Michael
    Ziepert, Marita
    Loeffler, Markus
    Merz, Hartmut
    Feller, Alfred C.
    BLOOD, 2007, 110 (11) : 936A - 936A
  • [6] Activity and safety of ibrutinib and durvalumab in patients with relapsed or refractory follicular lymphoma (FL) or diffuse large B-cell lymphoma (DLBCL)
    Herrera, A.
    Goy, A.
    Mehta, A.
    Ramchandren, R.
    Pagel, J.
    Svoboda, J.
    Guan, S.
    Hill, J.
    Kwei, K.
    Liu, E.
    Phillips, T.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E17 - E18
  • [7] Rituximab Fails to Reduce Histologic Transformation (HT) Rate of Follicular Lymphoma (FL) to Diffuse Large B-Cell Lymphoma (DLBCL)
    Marciscano, Ariel E.
    Gupta, Neel
    Zhang, Zhigang
    Teruya-Feldstein, Julie
    Noy, Ariela
    BLOOD, 2008, 112 (11) : 310 - 310
  • [8] Clinical Impact of the Presence of a Diffuse Large B-Cell Lymphoma (DLBCL) Component in the Outcome of Untreated Patients with Follicular Lymphoma (FL)
    Magnano, Laura
    Dlouhy, Ivan
    Balague, Olga
    Rivas-Delgado, Alfredo
    Rovira, Jordina
    Karube, Kennosuke
    Gonzalez, Blanca
    Martinez-Trillos, Alejandra
    Martinez, Antonio
    Delgado, Julio
    Gine, Eva
    Villamor, Neus
    Campo, Elias
    Lopez-Guillermo, Armando
    BLOOD, 2016, 128 (22)
  • [9] Diffuse large B-cell lymphoma (DLBCL)
    Renner, C.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 82 : S10 - S10
  • [10] Focal follicular features in tonsillar diffuse large B-cell lymphomas: Follicular lymphoma with diffuse areas or follicular colonization
    Ree, HJ
    Kikuchi, M
    Lee, SS
    Ohshima, K
    Yang, WI
    Ko, YH
    Cho, EY
    Rhee, JC
    HUMAN PATHOLOGY, 2002, 33 (07) : 732 - 740
12345